MedTrace Logo

Anabolic Steroids and Exercise in Hemodialysis Patients

NCT00250536 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-01-14

No results posted yet for this study

Summary

This is a study to find out whether an exercise program during dialysis or a drug called nandrolone decanoate can increase muscle size and strenght in patients on dialysis.

Conditions

  • End-Stage Renal Disease
  • Muscle Weakness

Interventions

DRUG

nandrolone decanoate

BEHAVIORAL

resistance exercise training

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Kirsten L Johansen, MD · University of California, San Francisco, San Francisco VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Completion
2004-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00250536 on ClinicalTrials.gov